Ranolazine for Diabetic Peripheral Neuropathic Pain (DPNP)

NCT02156336 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Not enough patients met study criteria for enrollment.

Conditions

Diabetic Peripheral Neuropathic Pain

Interventions

DRUG: Ranolazine
DRUG: Placebo

Sponsor

Horizons International Peripheral Group

Collaborators

[object Object]